Save the Children International, Bardibas 45701, Nepal.
Sahayog Samittee Nepal, Kalaiya 44412, Nepal.
Int J Environ Res Public Health. 2021 Nov 9;18(22):11762. doi: 10.3390/ijerph182211762.
In Nepal, 47% of individuals who fell ill with TB were not reported to the National TB Program in 2018. Approximately 60% of persons with TB initially seek care in the private sector. From November 2018 to January 2020, we implemented an active case finding intervention in the Parsa and Dhanusha districts targeting private provider facilities. To evaluate the impact of the intervention, we reported on crude intervention results. We further compared case notification during the implementation to baseline and control population (Bara and Siraha) notifications. We screened 203,332 individuals; 11,266 (5.5%) were identified as presumptive for TB and 8077 (71.7%) were tested for TB. Approximately 8% had a TB diagnosis, of whom 383 (56.2%) were bacteriologically confirmed (Bac+). In total, 653 (95.7%) individuals were initiated on treatment at DOTS facilities. For the intervention districts, there was a 17%increase for bacteriologically positive TB and 10% for all forms TB compared to baseline. In comparison, the change in notifications in the control population were 4% for bacteriologically positive, and -2% all forms. Through engagement of private sector facilities, our intervention was able to increase the number of individuals identified with TB by over 10% in the Parsa and Dhanusha districts.
在尼泊尔,2018 年有 47%的结核病患者未向国家结核病规划报告。大约 60%的结核病患者最初在私营部门寻求治疗。从 2018 年 11 月至 2020 年 1 月,我们在帕尔萨和丹库沙地区针对私营医疗机构实施了一项主动病例发现干预措施。为了评估干预措施的影响,我们报告了干预的初步结果。我们进一步将实施期间的病例报告与基线和对照人群(巴拉和锡拉哈)的报告进行了比较。我们共筛查了 203332 人;11266 人(5.5%)被认为患有疑似结核病,8077 人(71.7%)接受了结核病检测。约有 8%的人被诊断患有结核病,其中 383 人(56.2%)的结核病得到了细菌学证实(Bac+)。共有 653 人(95.7%)在 DOTS 设施开始接受治疗。与基线相比,干预地区的细菌阳性结核病和所有形式的结核病的报告率分别增加了 17%和 10%。相比之下,对照人群的细菌阳性和所有形式结核病的报告变化分别为 4%和-2%。通过与私营部门合作,我们的干预措施使帕尔萨和丹库沙地区的结核病患者数量增加了 10%以上。
Int J Environ Res Public Health. 2021-11-9
Kekkaku. 2002-10
Bull World Health Organ. 2004-2
Int J Tuberc Lung Dis. 2013-9
Afr J Prim Health Care Fam Med. 2015-3-27
Semin Immunopathol. 2018-10-25
J Infect Dis. 2017-11-6
Int J Tuberc Lung Dis. 2000-8